Discovery Europe 2025 features the co-location of 23rd Annual Drug Discovery Summit & Discovery Chemistry Europe and the 6th Annual Neuroscience Drug Development Europe Congresses.
Join and network with over 350 industry discovery biology and chemistry leaders at the renowned Drug Discovery Summit in Basel, where they address critical strategies in target identification, validation and HIT optimisation of small and large molecule drugs. The Drug Design & Medicinal Chemistry focused event also offer insightful innovations in Automation And Synthesis In Organic Chemistry as well as Molecular Drug Design.
Together with Neuroscience Drug Development Europe, attendees especially benefit from an event addressing emerging strategies for the drug development of neuroscience and successful approaches for more targeted, precise, and transformative therapies to neurodegenerative diseases.
Together with Neuroscience Drug Development Europe, attendees especially benefit from an event addressing emerging strategies for the drug development of neuroscience.
- The programme addresses drug discovery in new modalities such as protein degradation, and case studies on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling.
- Examine the latest advancements and emerging trends in developing neurological treatments, including targeted approaches and novel strategies.
- Learn about key focus areas in drug design including AI in drug design: in chemical synthesis, target ID capabilities & lead identification/optimisation.
